Ozempic vs Wegovy

Ozempic vs Wegovy: the short answer

For weight loss, Wegovy is the on-label choice and reaches a higher target dose. Ozempic is often easier to get covered because it is prescribed for diabetes. Cash prices are similar; coverage is what usually decides.

Both Ozempic and Wegovy contain semaglutide, so the core medicine is the same. The practical differences come down to approved use, target dose, and price.

On cost alone, Wegovy tends to be the cheaper option — its lowest realistic monthly price starts around $0, versus about $25 for Ozempic.

How each medication works

Ozempic is a GLP-1 receptor agonist taken as a once-weekly subcutaneous injection. It is FDA-approved for Type 2 diabetes, and is also used off-label for weight loss and weight management.

Wegovy is a GLP-1 receptor agonist taken as a once-weekly subcutaneous injection. It is FDA-approved for Chronic weight management and Cardiovascular risk reduction.

Because they share the same active ingredient, the main dosing difference is the target maintenance dose: 1 mg or 2 mg weekly for Ozempic versus 2.4 mg weekly for Wegovy.

Effectiveness: average weight loss

In clinical data, Ozempic was associated with roughly 12% average body-weight reduction over about 40 weeks (Semaglutide clinical data (SUSTAIN program); off-label for weight).

Wegovy was associated with roughly 15% over about 68 weeks (STEP 1 trial (semaglutide 2.4 mg)).

Head-to-head averages favor Wegovy, but individual results vary widely with dose, diet, activity, and how long you stay on treatment. These figures are trial averages, not guarantees.

Cost comparison

Ozempic: full cash price is around $969/mo. With a manufacturer savings program it can drop to about $25/mo, and telehealth routes run roughly $199–$499/mo.

Wegovy: full cash price is around $1,349/mo. With savings it can drop to about $499/mo, and telehealth routes run roughly $299–$599/mo.

Use the cost calculator to plug in your insurance status and state — the cheapest route often depends on coverage far more than on which drug you pick.

Side effects and safety

The most common side effects overlap heavily: Ozempic lists nausea, diarrhea, vomiting, and constipation; Wegovy lists nausea, diarrhea, vomiting, and constipation. Most are gastrointestinal and tend to ease as the dose is titrated up slowly.

Both carry serious warnings, including a boxed warning about the risk of thyroid C-cell tumors, and should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN 2. Only a licensed clinician can decide whether either is appropriate for you.

Insurance and how to get each

Ozempic: Frequently covered for type 2 diabetes; rarely covered when prescribed off-label for weight loss.

Wegovy: Covered by some commercial plans for obesity; Medicare added limited coverage tied to cardiovascular risk. Coverage varies widely by plan.

If coverage is denied, most people compare a manufacturer savings program against a telehealth subscription or a compounded alternative where it is still legally available.

Which should you choose?

Since Ozempic and Wegovy are the same molecule, the decision is usually about approval and access: pick the one your insurance is more likely to cover, or the one with the self-pay price that fits your budget.

Whichever you lean toward, run your specifics through the calculator and take our 60-second quiz to see which telehealth provider can actually get it to you for the least.